Important News

BioNJ Press Releases

BioNJ and Medidata Collaborate to Address Underrepresentation in Clinical Trials Across New Jersey

In a groundbreaking effort to support the recruitment of underrepresented communities in clinical trials across the United States, BioNJ, the life sciences trade association for New Jersey, has engaged Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, to evaluate the demographic representation in trials conducted within New Jersey. Continue Reading…

BioNJ’s Prestigious Speaker Roster for Its 12th Annual C-Suite Summit

TRENTON, N.J., Oct. 7, 2024 /PRNewswire/ — BioNJ is hosting its C-Suite Summit this Thursday, October 10, 2024, at the Bridgewater Marriott. In its twelfth year, the C-Suite Summit convenes executives from across the life sciences sector, representing a diverse array of companies — from early stage start-ups to established industry leaders, spanning both public and private sectors, as well as revenue-generating and pre-revenue enterprises. Together, they engage in insightful discussions on the critical issues shaping C-Suite decision-making as the industry strives to bring groundbreaking treatments to market. Continue Reading…

BioNJ Announces Strategic Collaboration with Tech Council Ventures to Boost Life Sciences Innovation

TRENTON, N.J., July 9, 2024 /PRNewswire/ — BioNJ, the membership trade association dedicated to fostering the life sciences ecosystem in New Jersey, is excited to announce a strategic collaboration with Tech Council Ventures. This collaboration aims to accelerate and facilitate life sciences deals, leveraging the strengths and connections of the BioNJ community and ecosystem members. Continue Reading…

BioNJ Announces Lineup for BioPartnering Conference

TRENTON, N.J., April 25, 2024 /PRNewswire/ — BioNJ is pleased to host its 14th Annual BioPartnering Conference on Tuesday, May 14, at the Liberty Science Center in Jersey City. Sponsored by J.P. Morgan, Johnson & Johnson and Morgan Lewis and hosted by Jersey City Economic Development Corp., the Conference will bring together life sciences executives, investors, strategics, academic collaborators and business development professionals for 1-1 partnering, Industry Connections (office hours with large biopharma companies), exhibits, company pitch presentations, plenary sessions and lots of networking — including a closing networking reception. Continue Reading…

BioNJ’s BioPartnering Conference Moving to the Liberty Science Center in Jersey City

TRENTON, N.J. (Dec. 13, 2023) – The 14th Annual BioNJ BioPartnering Conference will move to the Liberty Science Center in Jersey City on May 14, 2024. This announcement comes on the heels of the New Jersey Economic Development Authority’s recent commitment to invest $20 million in a new innovation hub as part of Liberty Science Center’s SciTech Scity. 

“We can’t think of a more exciting venue to host our 14th Annual BioPartnering Conference,” said Debbie Hart, President and CEO, BioNJ. “Entrepreneurs are the engine and fuel for new company creation – driving the next generation of therapies, diagnostics and tools in life sciences. And, for the last three decades, the Liberty Science Center has nurtured young scientists and shepherded future leaders in its mission to foster new innovation. Jersey City is the perfect backdrop for this important meeting where life sciences companies, large and small, will gather to explore collaboration opportunities.” Continue Reading…

BioNJ’s Prestigious Speaker Roster for 11th Annual C-Suite Summit

TRENTON, NJ (September 19, 2023) – BioNJ has released the agenda and speaker roster for its Eleventh Annual C-Suite Summit, taking place Friday, October 6, 2023, at the Bridgewater Marriott. The C-Suite Summit brings together life sciences executives representing a wide breadth of companies from early to late stage, public and private and revenue and pre-revenue to discuss the topics impacting C-Suite decision-making in bringing new innovative treatments to market. Continue Reading…

New Jersey Shines in New Report Outlining Best Practices in Innovation, Partnerships and Job Creation

A new report released at the Biotechnology Innovation Organization (BIO) International Convention last week touts New Jersey as a national leader in spurring innovation and stimulating industry and economic growth.

BIO, in partnership with the Council of State Bioscience Associations (CSBA), released “The U.S. Biosciences Industry in the States: Best Practices in Innovation, Partnerships, and Job Creation.” Now in its seventh edition, the report analyzes the latest legislative and regulatory economic development initiatives at the state and regional level that help support the growth and development of the bioscience sector in the respective states. Continue Reading…

BioNJ Releases New Report: Health Equity in Clinical Trials MBA Business Case Competition: Identifying Innovative Approaches to Strengthening Diversity Within Clinical Trials

TRENTON, N.J. (April 18, 2023) –  During today’s 13th Annual BioPartnering Conference, taking place live at The Palace in Somerset Park, BioNJ, New Jersey’s life sciences trade association, released its “Health Equity in Clinical Trials MBA Business Case Competition: Identifying Innovative Approaches to Strengthening Diversity Within Clinical Trials.” Continue Reading…

BioNJ Announces Lineup for BioPartnering Conference

TRENTON, N.J. (March 7, 2023) – BioNJ is pleased to host its 13th Annual BioPartnering Conference on Tuesday, April 18, 2023, at The Palace at Somerset Park, Somerset, NJ. Back in person after three years, the Conference will bring together life sciences executives, investors, academic collaborators and business development professionals for networking, 1-1 partnering (including in-person on the day of the Conference and virtual partnering throughout the rest of the week), company and start-up pitches, exhibits and plenary sessions. Continue Reading…

BioNJ Hosts Its Inaugural Health Equity in Clinical Trials MBA Business Plan Case Competition

TRENTON, N.J. (Dec. 6, 2022) – BioNJ, New Jersey’s life sciences trade association, hosted an Inaugural Health Equity in Clinical Trials MBA Business Plan Case Competition on Saturday, December 3, at Rutgers Business School. BioNJ’s Business Plan Case Competition, which is part of a broader BioNJ strategic initiative of Health Equity in Clinical Trials, was designed to promote the next generation of diverse clinical trial innovators and identify innovative approaches and successful models that can be used nationally to strengthen diversity in clinical trials and expand health equity. Continue Reading…

BioNJ Announces the Launch of Its Health Equity in Clinical Trials Initiative

TRENTON, NJ (September 27, 2022) – BioNJ, the voice of the life sciences industry in New Jersey, announced the launch of its Health Equity in Clinical Trials Initiative. Committed to the vision of Health Equity for All, BioNJ’s Health Equity in Clinical Trials Initiative will define concrete issues that can Continue Reading…

BioNJ Releases Speakers and Agenda for 2022 C-Suite Summit

FOR IMMEDIATE RELEASE TRENTON, NJ (September 15, 2022) – BioNJ has released the agenda and growing speaker roster for its Tenth Annual C-Suite Summit, taking place Tuesday, October 18, 2022 at the Bridgewater Marriott. The C-Suite Summit brings together life sciences executives representing a wide breadth of companies from early to late Continue Reading…

BioNJ Announces New Appointments and Team Promotions

TRENTON, NJ (July 12, 2022) – BioNJ, the trade association for New Jersey’s life sciences industry, announced that Ian McLaughlin, Ph.D., has joined the organization as Executive Director, Government Affairs. A life scientist by training, Ian most recently served as a Policy Analyst in the New Jersey Assembly Majority Office, working Continue Reading…

BioNJ in the News
2024

2023

2022
2021
2020
2019
2018
BioNJ BioLines Weekender Archive

Biolines Weekender is BioNJ’s e-newsletter featuring the latest happenings in R&D, as well as the incredible innovation coming from New Jersey’s robust life sciences ecosystem. Click here to subscribe to our mailing list.

2024

Weekender 12-13-24
Welcome to the latest edition of the BioLines Weekender… Scientist & Patient Perspectives: The Imperative for Mental Healthcare Innovation. Do you know someone with a mental health disorder? You probably know a few – 1,112,000 adults in New Jersey struggle with a mental health condition – more than 3x the population of Newark! With Patients facing stigma, barriers to care, and complicated journeys to reach a diagnosis, biopharmaceutical manufacturers are committed to finding innovative solutions to address the mental health crisis. More…

Weekender 11-22-24
Welcome to the latest edition of the BioLines Weekender… Earlier this month, BioNJ’s Vice President of Government Affairs, Dr. Ian McLaughlin, joined esteemed colleagues from Medidata to present groundbreaking findings from BioNJ’s whitepaper, “Health Equity in Clinical Trials: New Jersey Participant Demographics.” More…

Weekender 11-1-24
Welcome to the latest edition of the BioLines Weekender… Amidst a challenging landscape of policy developments, BioNJ remains deeply committed to supporting New Jersey’s thriving life sciences ecosystem and ensuring timely access to essential medicines for Patients. In support of the entrepreneurial community, Debbie Hart, President & CEO of BioNJ, testified last week in support of the New Jersey Commission on Science, Innovation and Technology(CSIT). Debbie was appointed by Governor Murphy to serve as the Chair of the Commission. Recognizing CSIT’s transformative impact on early-stage innovation across the State, BioNJ is hopeful that the Commission will receive the necessary funding resources to help New Jersey maintain its’ position as a leading hub for innovation. More…

Weekender 10-18-24
Welcome to the latest edition of the BioLines Weekender… In a groundbreaking effort to support the recruitment of underrepresented communities in clinical trials across the United States, BioNJ engaged Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, to evaluate the demographic representation in trials conducted within New Jersey. More…

Weekender 10-04-24
Welcome to the latest edition of the BioLines Weekender…
A SPECIAL INVITATION TO BioNJ MEMBERS… On December 10, BioNJ is excited to unite our Members for “BioNJ Gives Back,” a special volunteer initiative where industry colleagues can brighten the lives of pediatric Patients across the State. Participants will build a BioBear, design a superhero cape and write a personal message of encouragement — all of which will be donated to a pediatric charity. Member companies can send up to five representatives to one of our two volunteer locations at no cost, making this a wonderful opportunity to come together, give back and make a meaningful impact. More…

Weekender 09-20-24
Welcome to the latest edition of the BioLines Weekender… High out-of-pocket costs are increasingly impacting Patients, with three in four adults reporting being very or somewhat worried about being able to afford the cost of health care services for themselves and their families. To help counteract these obstacles, biopharmaceutical manufacturers and non-profit organizations provide support to Patients to help them afford their copayments and access the treatments they need. More…

Weekender 09-06-24
Welcome to the latest edition of the BioLines Weekender… Following the passing of beloved New Jersey Congressman Bill Pascrell, last week the State Democratic Party nominated State Senator Nellie Pou (D-LD35) to run as the party’s candidate to represent New Jersey’s 9th congressional district. Senator Pou will run against Republican Billy Prempeh in November and, if elected, she will be the first Latin American woman to represent New Jersey in Congress. We now await the party’s decision as to whom they will select to fill Senator Pou’s seat in the State Senate. More…

Weekender 08-23-24
Welcome to the latest edition of the BioLines Weekender… We at BioNJ are profoundly saddened by the passing of Representative Bill Pascrell, a devoted public servant who dedicated his life to championing the needs of the people of New Jersey. Congressman Pascrell’s distinguished career spanned decades, beginning with his service in the State General Assembly in 1988 and continuing through his tenure in the U.S. House of Representatives since 1997. As Chair of the Subcommittee on Oversight for the Committee on Ways and Means, he remained open to the views and needs of the life sciences community throughout the years. More…

Weekender 08-09-24
Welcome to the latest edition of the BioLines Weekender… At the end of July, Governor Murphy signed a bill, with first prime sponsors Senator Mukherji (D, LD32) and Assemblyman Tully (D, LD38), that will establish the Next New Jersey Program for artificial intelligence (AI) investments. The legislation enables the New Jersey Economic Development Authority (NJEDA) to provide tax credits to eligible AI businesses. More…

Weekender 07-25-24
Welcome to the latest edition of the BioLines Weekender… On Monday, BioNJ hosted a Patient Advocate/Legislator Roundtable discussion with policymakers focused on opportunities for New Jersey to support increased Patient access to new and emerging medications — as well as opportunities to support the early-stage innovation that produces novel therapeutics. Held at BioNJ Member PsychoGenics’ facility in Paramus, which is led by BioNJ Chair Dr. Emer Leahy who kicked off the event, representatives from a variety of mental health and rare disease Patient advocacy organizations joined the discussion, including several members of the recently-appointed New Jersey Rare Disease Advisory Council. More…

Weekender 07-12-24
Welcome to the latest edition of the BioLines Weekender… Earlier this week, the Federal Trade Commission (FTC) released an interim staff report examining the impacts of vertical integration involving pharmacy benefit managers (PBMs). The report found that this dynamic has enabled PBMs to effectively control both the availability and pricing of essential medications for Patients. More…

Weekender 06-28-24
Welcome to the latest edition of the BioLines Weekender… BioNJ — in partnership with the Garden State Pharmacy Owners, representing over 800 independent community pharmacies across New Jersey — published an op-ed, entitled “Health Care Middlemen Don’t Benefit NJ Patients or Pharmacists” in NJ Spotlight News earlier this week. More…

Weekender 06-07-24
Welcome to the latest edition of the BioLines Weekender… Fresh off the red-eye, the New Jersey Delegation, led by Choose New Jersey and BioNJ, has returned from a bustling and successful BIO Convention in San Diego. During the event, we released the 2024 New Jersey Life Sciences Report, highlighting New Jersey’s thriving life sciences ecosystem and its position as a national leader in market access, affordable real estate and world-class talent. At the Convention, Choose NJ, BioNJ, the NJ Economic Development Authority, the NJ Commission on Science, Innovation and Technology, along with academic and other partners, showcased New Jersey while making countless connections, engaging in nonstop networking, promising prospecting, and perhaps even having a little fun. More…

Weekender 05-24-24
Welcome to the latest edition of the BioLines Weekender… Last week, a bill that would increase the investment incentives under New Jersey’s Angel Investor Tax Credit from 20% to 35%, along with an increase to 40% for investments in companies located in Opportunity Zones throughout the State, was reported by the Assembly Science, Innovation and Technology Committee (A2365). BioNJ is thrilled to see this prudent policy make progress and will continue to support its approval by the Legislature and ultimate signature by the Governor. More…

Weekender 05-03-24
Welcome to the latest edition of the BioLines Weekender… Things remain quite active on the policy front. Notably, given the recent reports that a representative of AARP is being considered for appointment to the State’s Prescription Drug Affordability Council, BioNJ is hopeful that the established relationships that AARP has with insurers will be contemplated prior to appointment. If the Council is intended to conduct unbiased assessments of what drives the costs that Patients confront, it will be most effective if its members are both knowledgeable and truly independent. More…

Weekender 04-19-24
Welcome to the latest edition of the BioLines Weekender… As Patients in New Jersey continue to face barriers to access their medications, organizations like the Institute for Clinical and Economic Review (ICER) continue to rely on discriminatory metrics to assign value to prescription medicines. The Quality Adjusted Life Year (QALY) methodology is subjective and threatens to discriminate against Patients who may never achieve what the QALY considers to be a perfect quality of life. More…

Weekender 04-05-24
Welcome to the latest edition of the BioLines Weekender… BioNJ is excited to announce the launch of its new and improved Talent Career Portal! Click here to explore the benefits of our new Career Center — including BioNJ’s Job Board! BioNJ’s Talent Career Portal was specifically designed to bring together top talent with leading companies in the New Jersey region. Featuring a state-of-the-art platform, both job seekers and hiring managers benefit from a sophisticated search engine as well as many user-friendly features. With companies like Ferring Pharmaceuticals, Genmab, Hovione, Legend Biotech, Novartis and Phathom Pharmaceuticals posting new jobs, BioNJ’s Talent Career Portal is THE place where life sciences applicants go to find their next job opportunity. More…

Weekender 03-15-24
Welcome to the latest edition of the BioLines Weekender… At BioNJ, we know that every Patient has a unique journey. As many Patient populations in New Jersey and beyond struggle to access the medicines they need, it is critical that policymakers consider Patient perspectives to make informed decisions about treatment and care. To empower advocates and Patients to raise their voice to support treatment access and medical innovation, BioNJ has created an educational guide around ways to join the conversation and best practices for engaging with policymakers, regulators and the media. More…

Weekender 03-01-24
Welcome to the latest edition of the BioLines Weekender… As many of you know, BioNJ has been working diligently to increase health equity in clinical trials over the past 24 months. To support the many companies in New Jersey want to increase diversity in clinical trials, BioNJ created a platform through which companies can exchange strategies and share their initiatives. The BioNJ Best Practices Database is a place where companies can share their work and projects and industry professionals can find examples from which to learn. More…

Weekender 02-16-24
Welcome to the latest edition of the BioLines Weekender… In December, the Biden administration announced a proposed framework for the use of March-In Rights, as part of the White House’s broader efforts around the prices of prescription drugs. According to the Bayh-Dole Coalition and other stakeholders, the proposal may deter public-private collaborations to advance new treatments and cures, and it will decimate confidence in the reliability of universities and federal laboratories as R&D partners, severely handicapping American innovation. More…

Weekender 02-02-24
BioNJ’s Annual Dinner Meeting is Nearing Capacity! Considered the kickoff event of the year for the life sciences industry, BioNJ’s 31st Annual Dinner Meeting & Innovation Celebration, taking place NEXT THURSDAY, February 8 at the Hilton East Brunswick, will bring together New Jersey’s life sciences community to celebrate the medical innovation coming from the Garden State. More…

Weekender 01-19-24
Welcome to the latest edition of the BioLines Weekender… Act Now to Restore Immediate R&D Expensing & Protect Our Innovation Economy. Due to a 2017 law, beginning in 2022, U.S. businesses can no longer deduct research and experimentation expenses in the same taxable year. Now companies are forced to amortize such deductions over five years for domestic expenditures or over 15 years for foreign expenditures. Sadly, this results in a significant reduction of capital, taking resources away from small R&D-intensive companies. Redirecting funds from research to pay for unexpected tax bills jeopardizes the development of future treatments, cures and scientific discoveries. More…

Weekender 01-05-24
Welcome to the latest edition of the BioLines Weekender… Join us on Thursday, February 8, 2024, at the Hilton East Brunswick, for the industry’s kickoff event of the year in New Jersey! BioNJ’s 31st Annual Dinner Meeting & Innovation Celebration will bring hundreds of biopharma professionals, academic leaders, Patients, advocates, service providers and government officials together to honor the groundbreaking medical innovation coming from the Garden State. More…

2023

Weekender 12-15-23

Welcome to the latest edition of the BioLines Weekender… As we close out the year, I want to say thank you to our Members for your unrelenting work on behalf of Patients and for your engagement in BioNJ. Thank you also to our Board, our Sponsors and all of our Partners for all that you do to make a difference for Patients, for BioNJ and our life sciences ecosystem every day. More…

Weekender 12-01-23

Welcome to the latest edition of the BioLines Weekender… Help Hold PBMs Accountable and Encourage Transparency in the Industry It’s very possible you’ve never heard of a pharmacy benefit manager (PBM) but if you take prescription medicine, they could be costing you money.

PBMs and insurance companies work together to decide what medicines will be covered by insurance and the price of those drugs. While the concept was designed to help people save money, the reality is that the largest 6 PBMs control almost 96% of the PBM market. The largest 3 (Optum, Express Scripts, and CVS Caremark) themselves control 80% of that market. This gives PBMs inordinate power to set prices, deny coverage and pad their bottom line instead of passing the savings along to people who need medicine. More…

Weekender 11-10-23

Welcome to the latest edition of the BioLines Weekender… It was an action-packed election this week, as all 120 seats in the New Jersey State Legislature were up for a vote. And while there had been an expectation that the majorities held by Democrats in the State Senate and Assembly might have diminished going into election day, the margin of the party’s majority in the Assembly will expand by five seats and remain the same in the Senate. More…

Weekender 10-27-23

Welcome to the latest edition of the BioLines Weekender… Building on Governor Murphy’s recently signed executive order establishing an Artificial Intelligence Task Force charged with studying emerging artificial intelligence (AI) technologies, BioNJ is proud to host its inaugural AI & Digital Health Day, in partnership with Morgan Stanley and DLA Piper, next Wednesday, November 1. More…

Weekender 10-13-23

Welcome to the latest edition of the BioLines Weekender… On the heels of our recently debuted Health Equity in Clinical Trials Best Practices Database featuring a diverse array of initiatives being offered by the community, BioNJ hosted it’s first-ever BioNJ Health Equity in Clinical Trials Best Practices Webinar focused on “Examples from Which to Learn & Opportunities for Collaboration” on September 21. More…

Weekender 09-22-23

Welcome to the latest edition of the BioLines Weekender… BioNJ recently released the speaker roster for our Eleventh Annual C-Suite Summit, entitled “Chasing Breakthrough Innovation in a Time of Uncertainty,” taking place Friday, October 6, 2023, at the Bridgewater Marriott. More…

Weekender 09-08-23

Welcome to the latest edition of the BioLines Weekender… BioNJ has been working diligently to increase health equity in clinical trials over the past 18 months. While many companies in New Jersey want to increase diversity in clinical trials, there is currently no unified platform through which companies can exchange strategies and share their initiatives. Therefore, BioNJ created a Best Practices Database – where companies can share their work and projects and industry professionals can find examples from which to learn. More…

Weekender 08-25-23

Welcome to the latest edition of the BioLines Weekender… As we approach the final quarter of the year, and organizations are planning for 2024, talent is likely a part of the equation. Core to BioNJ’s mission is to help companies find the quality candidates that they need to drive medical innovation forward. More…

Weekender 08-11-23

Welcome to the latest edition of the BioLines Weekender… As the voice of the life sciences industry in New Jersey, BioNJ advocates in both Trenton and Washington D.C. to ensure that government fosters medical innovation and Patient access. In doing so, BioNJ launched its Value of Medical Innovation Campaign three years ago with three objectives in mind: 1) To educate key audiences on the value of medical innovation, 2) to build an army in the form of a database of grassroots advocates that we can call upon to activate “hands-on” campaigns to legislators, and 3) to engage with Patient advocates on policy threats. More…

Weekender 07-28-23

Welcome to the latest edition of the BioLines Weekender… We would like to congratulate Health Commissioner Judith Persichilli on her upcoming retirement. In 2022, BioNJ had the honor of presenting Commissioner Persichilli with the Dr. Sol J. Barer Award for Vision, Innovation and Leadership for her tireless work on behalf of Patients and her unwavering dedication as she led the State’s response to the COVID-19 pandemic. More…

Weekender 7-7-23

Welcome to the latest edition of the BioLines Weekender… BioNJ has been working diligently to increase health equity in clinical trials over the past 18 months. While many companies in New Jersey want to increase diversity in clinical trials, there is currently no unified platform through which companies can exchange strategies and share their initiatives. Therefore, BioNJ created a Best Practices Database – where companies can share their work and projects and industry professionals can find examples from which to learn. More…

Weekender 6-23-23

Welcome to the latest edition of the BioLines Weekender… Earlier this month, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released “The U.S. Biosciences Industry in the States: Best Practices in Innovation, Partnerships and Job Creation,” which analyzes the latest legislative and regulatory economic development initiatives at the state and regional level that help support the growth and development of the bioscience sector in the respective states. More…

Weekender 6-9-23

Welcome to the latest edition of the BioLines Weekender… The New Jersey delegation, including five BioNJ Team members, is just back from the BIO Convention in Boston. What an amazing time it was with the New Jersey Pavilion strategically and visibly positioned and full of energy throughout with meetings happening with potential partners from around the world, including life sciences industry executives, government officials, academic institutions and more who wanted to learn about New Jersey. More…

Weekender 5-26-23

Welcome to the latest edition of the BioLines Weekender… If you haven’t done so yet, take a look at BioNJ’s recently released whitepaper, entitled “Health Equity in Clinical Trials MBA Business Case Competition: Identifying Innovative Approaches to Strengthening Diversity Within Clinical Trials.” The paper provides an overview of BioNJ’s Inaugural Health Equity in Clinical Trials MBA Business Plan Case Competition and features highlights from all the submitted business plans, summaries of proposals that received top awards, and learnings from the inaugural competition. More…

Weekender 5-12-23

Welcome to the latest edition of the BioLines Weekender… Yesterday, S1615 and S1616 — two bills in the package of legislation focused on prescription drugs — moved through the New Jersey Senate Budget and Appropriations Committee. S1615, which establishes data reporting requirements for manufacturers, was amended to incorporate language that eliminates advance notice provisions in addition to a variety of other changes. S1616, which addresses the business practices of Pharmacy Benefit Managers (PBMs), moved through the committee without amendments. More…

Weekender 4-28-23

Welcome to the latest edition of the BioLines Weekender… Last week, BioNJ released a new whitepaper, entitled “Health Equity in Clinical Trials MBA Business Case Competition: Identifying Innovative Approaches to Strengthening Diversity Within Clinical Trials.” The paper provides an overview of BioNJ’s Inaugural Health Equity in Clinical Trials MBA Business Plan Case Competition and features highlights from all the submitted business plans, summaries of proposals that received top awards, and learnings from the inaugural competition. More…

Weekender 4-7-23

Welcome to the latest edition of the BioLines Weekender… The process involved in bringing a medical treatment, product, or device from the research stage into the hands of Patients, including the process of drug pricing, is a complex one that involves a range of policies and stakeholders across the healthcare system. More…

Weekender 3-24-23

Welcome to the latest edition of the BioLines Weekender… Core to BioNJ’s mission is to help companies find the quality candidates that they need to drive medical innovation forward. BioNJ’s Talent Services Career Portal was specifically designed to bring together top talent with leading companies in the New Jersey region. Featuring a state-of-the-art platform, both job seekers and hiring managers benefit from a sophisticated search engine as well as many user-friendly features. More…

Weekender 3-10-23

Welcome to the latest edition of the BioLines Weekender… Right now, there are middlemen in the healthcare system – known as pharmacy benefit managers or PBMs – playing a significant role in how Patients access and afford their prescription medications. While they operate with little to no transparency, these PBMs contribute to lower levels of treatment adherence and worse healthcare outcomes for Patients living with complex conditions such as autoimmune diseases, HIV and cancer. More…

Weekender 2-24-23

Welcome to the latest edition of the BioLines Weekender… It has never been more important for the life sciences community to come together and support and learn from one another. Being that BioNJ’s mission is to help our Members help Patients, we are dedicated to working hard on behalf of our Members — while you are hard at work for Patients. More…

Weekender 2-10-23

Welcome to the latest edition of the BioLines Weekender… The industry came out to honor New Jersey’s innovative life sciences companies and leaders, as well as the Patients who inspire them, last Thursday night at BioNJ’s 30th Annual Dinner Meeting and Innovation Celebration. More…

Weekender 1-27-23

Welcome to the latest edition of the BioLines Weekender… BioNJ’s 30th Annual Dinner Meeting & Innovation Celebration is NEXT WEEK — taking place on Thursday, February 2, 2023, at the Hilton East Brunswick. Hundreds of biotechnology and pharmaceutical professionals, academic leaders, Patients, advocates and service providers – including BioNJ’s Board of Trustees – are coming together for an action-packed evening featuring an networking cocktail reception, dinner program, dessert reception and awards presentation. Click here to join the festivities. More…

Weekender 1-13-23

Welcome to the latest edition of the BioLines Weekender… Considered the meeting place for the life sciences industry in New Jersey, BioNJ’s 30th Annual Dinner Meeting & Innovation Celebration is less than one month away — taking place on Thursday, February 2, 2023, at the Hilton East Brunswick. Because Patients Can’t Wait®, we are so proud of our Members who are helping Patients live longer, better lives. And, we are pleased to celebrate their important work and dedication during the Annual Dinner Meeting. Hundreds of biotechnology and pharmaceutical professionals, academic leaders, Patients, advocates, service providers and government officials will come together for an action-packed evening, including an opening cocktail reception, dinner program, dessert reception and awards presentation. More…

2022

Weekender 12-22-22

Welcome to the latest edition of the BioLines Weekender…
As we close out the year, I want to say thank you to our Board for their commitment to BioNJ and to our Members for your unrelenting work on behalf of Patients as well as to our incredibly dedicated and hard-working BioNJ Team. And congratulations on several well-deserved promotions including More…

Weekender 12-09-22

Welcome to the latest edition of the BioLines Weekender…
BioNJ hosted its Inaugural Health Equity in Clinical Trials MBA Business Plan Case Competition this past Saturday, December 3, at Rutgers University Business School. Part of a broader BioNJ strategic initiative of Health Equity in Clinical Trials, the Business Plan Case Competition was designed to promote the next generation of diverse clinical trial innovators and identify innovative approaches and successful models that can be used nationally to strengthen diversity in clinical trials and expand health equity. More…

Weekender 11-04-22

Welcome to the latest edition of the BioLines Weekender…
TEConomy/BIO’s Report Confirms New Jersey’s Continued National Industry Leadership. The U.S. biotech sector is a vital economic engine in all 50 states, providing 2.1 million jobs and a $2.9 trillion impact on the economy in 2021, according to a comprehensive report published by the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) in partnership with TEConomy. More…

Weekender 10-21-22

Welcome to the latest edition of the BioLines Weekender…
Committed to the vision of Health Equity for All, BioNJ has launched a Health Equity in Clinical Trials Initiative, with the intention to define concrete issues that can be remedied with impact, identify long-term interventions, support companies to improve equity and access in their clinical trials strategies, benchmark best practices and shape policy. More…

Weekender 10-07-22

Welcome to the latest edition of the BioLines Weekender…
Calling all BioNJ Members! Join us next Wednesday, October 12, for BioNJ’s Member Café — ‘open’ exclusively to BioNJ Members. Taking place virtually, BioNJ’s Member Café offers Members an interactive environment to engage with old friends and build new relationships. In addition to networking with fellow BioNJ Members, you’ll enjoy updates on upcoming events, cost-saving business solutions and industry news. More…

Weekender 09-23-22

New Jersey’s innovative life sciences industry develops groundbreaking treatments and cures upon which Patients everywhere depend. Medical innovation also supports a healthy New Jersey economy. But a threat is looming. Patients and innovation itself may be endangered. More…

Weekender 09-09-22

Welcome to the latest edition of the BioLines Weekender…
As we approach the final quarter of the year and organizations are planning for 2023, talent is likely a part of the equation. Core to BioNJ’s mission is to help companies find the quality candidates that they need to drive medical innovation forward. More…

Weekender 08-26-22

Welcome to the latest edition of the BioLines Weekender…
On August 16, President Biden signed the Inflation Reduction Act into law ─ legislation that is going to harm Patient access to innovative medicines by allowing government price setting on new treatments. Unfortunately, this legislation fails to address one of the true drivers of high costs in the healthcare system: industry middlemen known as pharmacy benefit managers (PBMs). PBMs negotiate rebates and fees with drug manufacturers, create drug formularies and reimburse pharmacies for Patients’ prescriptions. However, far too often, PBMs fail to pass along these manufacturer rebates and discounts to Patients at the pharmacy counter. More…

Weekender 07-29-22

Welcome to the latest edition of the BioLines Weekender…
The Senate Parliamentarian will be reviewing a new version of the Build Back Better package, now called the Inflation Reduction Act of 2022, following an agreement between Senators Manchin and Schumer on Wednesday, July 27. The new legislation would be more expansive than the preceding version, and continues to include provisions associated with drug pricing. The Senate is expected to consider the legislation sometime next week, contingent on the findings of the Parliamentarian regarding whether it would be viable for the reconciliation process, which requires only a simple majority vote but must have some direct budgetary relevance. More…

Weekender 07-01-22

Welcome to the latest edition of the BioLines Weekender…
Last week, BioNJ President and CEO Debbie Hart had the opportunity to sit down with two early BioNJ leaders, Drs. Don and Lisa Drakeman, for an insightful discussion of their new book, “From Breakthrough to Blockbuster: The Business of Biotechnology.” More…

Weekender 06-17-22

Welcome to the latest edition of the BioLines Weekender…
The industry came out to honor New Jersey’s innovative life sciences companies and leaders, as well as the Patients who inspire them, last Thursday night at BioNJ’s 29th Annual Dinner Meeting and Innovation Celebration. More…

Weekender 06-02-22

Welcome to the latest edition of the BioLines Weekender…
Core to BioNJ’s mission to help our Members help Patients is BioNJ’s Value of Medical Innovation Campaign. The goal of the campaign is to educate and engage with legislators, advocates and our community on the value of medical innovation as well as policy threats to Patients, innovation and health care equity. From health care affordability to misconceptions about PBMs and PDABs and, of course ICER, there is still lots of work to be done. More…

Weekender 05-20-22

Welcome to the latest edition of the BioLines Weekender…
BioNJ Members work tirelessly to bring cures to Patients who need them. From COVID-19 vaccines to therapies for devastating diseases, these cutting-edge treatments reduce overall health care costs and improve the quality of life for Patients and those who care for them. BioNJ is committed to ensuring Patients have access to medications they need when they need them while safeguarding future medical innovation. More…

Weekender 05-06-22

Welcome to the latest edition of the BioLines Weekender…
The BioNJ Team is busy preparing for next week’s BioPartnering Conference in partnership with J.P. Morgan and Johnson & Johnson Innovation, May 9-13. We have 500 registered from 10 countries, 16 states and the District of Columbia — representing public and private company investors (over 100 investors!), industry executives and institution and partnering professionals. More…

Weekender 04/08/22

Welcome to the latest edition of the BioLines Weekender…
The BioNJ Team has been busy preparing for a number of upcoming events, including our popular BioPartnering Conference in partnership with J.P. Morgan and Johnson & Johnson Innovation, May 9-13. This year’s Conference will kick off with an in-person Networking Reception at The Liberty House in Jersey City, NJ. An up-and-coming life sciences hub, come enjoy the excitement of Jersey City while connecting with other industry professionals. Click here for the full agenda, including 1:1 partnering, plenary sessions and company presentations. More…

Weekender 03/25/22

Welcome to the latest edition of the BioLines Weekender…
Core to BioNJ’s mission is helping companies find the talent they need to ensure New Jersey’s life sciences ecosystem has the required expertise to drive medical innovation forward. With this in mind, BioNJ’s Talent Services Career Portal was specifically designed to bring together top talent with leading companies in the New Jersey region. More…

Weekender 03/11/22

Welcome to the latest edition of the BioLines Weekender…
As our BioNJ community looks for ways to help during these horrific times in the Ukraine, we wanted to provide you with several charities, shared by our Members, that you or your organizations may be interested in supporting. Each Group has received high marks for efficiency and transparency. More…

Weekender 2/25/22

Welcome to the latest edition of the BioLines Weekender…
Calling all BioNJ Members!
With a New Year comes new opportunities! BioNJ is excited to announce our NEW Member Café — ‘open’ exclusively to BioNJ Members. Taking place virtually the second Wednesday of every month, BioNJ’s Member Café offers Members an interactive environment to engage with old friends and build new relationships. In addition to networking with fellow BioNJ Members, you’ll enjoy updates on upcoming events, cost-saving business solutions and industry news. More…

Weekender 2/4/22

Welcome to the latest edition of the BioLines Weekender…
Things are getting busy once again in both Trenton and Washington. Yesterday, A-1747/S-329, legislation to create a Prescription Drug Affordability Board, was heard and released by the Assembly Financial Institutions and Insurance Committee. BioNJ President and CEO Debbie Hart was on hand to testify with a message that a Prescription Drug Affordability Board is the wrong way to lower Patient out-of-pocket costs. Rather than taking a systemwide, holistic approach that addresses the drug supply chain middlemen, coinsurance, co-payments and health benefit design issues that can have the biggest impact on Patient costs, PDAB proposals focus squarely on the innovative biopharmaceutical sector without any guarantee of Patient savings on necessary and lifesaving prescription treatments. Click here for BioNJ’s whitepaper which demystifies some of the myths commonly used in support of Prescription Drug Affordability Board proposals. More…

Weekender 1/21/22

Welcome to the latest edition of the BioLines Weekender…
BioNJ is sad to learn of the passing of Dr. Bonita Stanton, the founding dean of the Hackensack Meridian School of Medicine. Dr. Stanton will be remembered for her extraordinary leadership — forever transforming the health care and innovation landscape in New Jersey. She will be missed and her legacy will live on. More…

Weekender 1/7/22

Welcome to the first edition of the BioLines Weekender for 2022!
Happy New Year! With the onset of 2022 comes new hope and encouragement for fresh opportunities and possibilities. Our industry remains focused and dedicated to what it does best…bringing new medical innovation to Patients throughout the world! Although 2021 proved to be challenging as we continued our fight against COVID-19, New Jersey’s robust life sciences ecosystem didn’t miss a beat with 34 new FDA drug approvals – representing nearly 40% of all new approvals! More…

2021
Weekender 12/10/2021

Things on the policy front have been heating up with the New Jersey Legislature’s post-election “lame duck” session continuing through mid-January.

In particular, BioNJ continues to urge lawmakers in New Jersey to oppose A-2418/S-1066 which would threaten Patients, health equity and the very innovations that so many Patients rely on. Prescription Drug Affordability Boards provide little in terms of savings to consumers and impede the investment needed by small and emerging biopharmaceutical companies working to discover tomorrow’s cures. Recently, BioNJ released a white paper, “Prescription Drug Affordability Boards: Myths vs. Facts on Drug Supply Chain,” that corrects the record on several common myths about Prescription Drug Affordability Boards (PDAB) and explains their harmful impact. More…

Weekender 11/19/2021

Earlier this week, BioNJ announced its roster of notable speakers for BioNJ’s Seventh Annual Inspiring Women in STEM Conference, taking place virtually on Friday, December 3. The Conference is designed to bring together the life sciences community to share anecdotes, tools and resources to support women involved in all aspects of science, technology, engineering and math. More…

Weekender 11/5/2021

An incredibly important and busy week on so many fronts: the NJ Election, the ongoing Drug Pricing debate in DC and today’s White House release of vaccine requirements for employers. Not for the faint of heart! See BioNJ’s Public Policy Update for the New Jersey Election and Drug pricing news by clicking here.And the link for the White House Vaccination Policies here.

Meanwhile, an incredible lineup of speakers is in place for BioNJ’s Inspiring Women in STEM Conference on December 3. Check out the program here.

Weekender 10/22/2021

Thank you to everyone who joined us last Friday for BioNJ’s 9th Annual C-Suite Summit. From Dr. Peter Marks of the FDA to Dr. Michael Ku of Pfizer, we were excited to have assembled a roster of world-class leaders to consider this past year’s successes and challenges, the next wave of innovation across the value chain and how the industry might deepen and scale its commitment to delivering a positive impact for society. More…

Weekender 10/8/2021

Last week, BioNJ released a new white paper, “Prescription Drug Affordability Boards: Myths vs. Facts on Drug Supply Chain,” that corrects the record on several common myths about Prescription Drug Affordability Boards (PDAB) and their harmful impact on Patients and the medical innovation ecosystem. The BioNJ white paper concludes that policymakers should avoid the creation of a PDAB as a means to control drug costs and should instead adopt solutions that will improve Patient access and deliver savings to the health care system, such as capping Patient out-of-pocket costs and using negotiated rebates to provide savings to Patients. More…

Weekender 9/24/2021

BioNJ recently released the speaker roster for our Ninth Annual C-Suite Summit,entitled “Transitional to the ‘Next Normal’: Biopharma’s Role in Addressing the COVID-19 Crisis and What’s Next,” taking place virtually Friday, October 15, 2021,from 8:30 a.m.-2:15 p.m. After closely monitoring updates from the Centers for Disease Control and Prevention and State and local health agencies, as well as speaking with leading epidemiologists, BioNJ has decided to present this year’s full-day C-Suite Summit virtually, instead of its originally planned in-person format. More…

Weekender 9/10/2021

We are excited to announce BioNJ’s new Value of Medical Innovation Blog. In our first edition, Alliance for Patient Access (AfPA) Executive Director Josie Cooper explains how the Institute for Clinical and Economic Review (ICER) undermines the critical relationship between patients and their providers with its “one-size-fits-all” approach to drug value assessment.

Weekender 8/27/2021

As Labor Day approaches, the BioNJ Team has been busy planning for our upcoming events schedule. Whether in-person or virtual, BioNJ is committed to bringing you quality programming featuring informative plenary sessions as well as interactive networking opportunities.

Weekender 8/13/2021

Earlier this week, BioNJ opened registration for our first live (fingers crossed that we do not need to revert to a virtual experience) event of 2021! Please join us on Friday, October 15, for BioNJ’s Ninth Annual C-Suite Summit, where we’ll reflect on this past year’s successes and challenges, discuss the next wave of innovation across the value chain and share thoughts on how the industry can deepen and scale its commitment to delivering a positive impact for society. Click here for the program agenda and growing list of speakers. We are looking forward to seeing you and your colleagues in-person!

Weekender 7/30/2021

As the country — and the nation — continue to navigate the new “norm” in the era of COVID-19, we, at BioNJ, are extremely proud of the unwavering commitment and tireless work being done by the life sciences industry here in New Jersey. The Garden State has gallantly led the way in research for testing, antivirals, therapeutics and vaccines against this devastating virus.

Weekender 7/16/2021

Core to BioNJ’s mission is helping companies find the talent they need to ensure New Jersey’s life sciences ecosystem has the required expertise to drive medical innovation forward. With this in mind, BioNJ’s Talent Services Career Portal was specifically designed to bring together top talent with leading companies in the New Jersey region.

Weekender 6/25/2021

The COVID-19 pandemic necessitated changes in nearly every aspect of our lives. Nowhere was this more apparent than in our health care system. Among the hardest hit states in the early days of the pandemic, New Jersey’s health care system immediately stepped to the plate to treat and triage COVID-19 Patients. Additionally, the Garden State’s vibrant life sciences ecosystem delivered unprecedented innovation — from providers and others adapting to a new and unknown virus to the ongoing research and development of vaccines and treatments that have played a major factor in our return to “normal.”

Weekender 6/11/2021

As the world continues to navigate the “new” norm, it has never been more important for the life sciences community to come together and support and learn from one another. BioNJ is dedicated to working hard on behalf of our Members — while you are hard at work for Patients. Make sure to take advantage of all the value-driven opportunities available to your organization through your BioNJ Membership.

Weekender 5/28/2021

Thank you to everyone who joined us last week for BioNJ’s 11th Annual BioPartnering Conference. Presented in concert with J.P. Morgan and Johnson & Johnson Innovation on May 18 and 19, the Conference brought together life sciences professionals from 9 countries and 20 states as well as the District of Columbia and featured nearly 70 company and pitch presentations, hundreds of 1:1 partnering meetings and plenary sessions led by industry leaders and world-renowned research institutions from the region.

Weekender 5/14/2021

We hope to see you next week at BioNJ’s Virtual BioPartnering Conference, developed and presented in concert with J.P. Morgan and Johnson & Johnson Innovation. Taking place May 18 and 19, BioNJ’s BioPartnering Conference is a unique opportunity to connect with life sciences executives, investors, institutional collaborators and business development professionals; schedule 1:1 meetings with potential partners; present and watch Company and Start-up Pitch Presentations; hear from industry experts; discuss business and research opportunities with world-renowned institutions and network directly with other conference attendees. Click here for a list of topics and speakers.

Weekender 4/30/2021

COVID-19 has exposed just how vulnerable so many communities are in the face of disease and just how critical access to necessary treatment is to protecting and maintaining patient health. The pandemic has also exposed how deep health inequities continue to leave many underserved communities behind. Unfortunately, lawmakers are increasingly looking to the Institute for Clinical and Economic Review (ICER) and drug value assessment frameworks for how to accurately price new and innovative medical treatments — many of which are being developed by life sciences companies that call New Jersey home. ICER uses the “Quality Adjusted Life Years” (QALY) methodology to determine the value of new drugs and then issues reports on these therapies when they come to the market.

Weekender 4/16/2021

The COVID-19 pandemic has necessitated changes in nearly every aspect of our lives during the last year. Nowhere has this been more apparent than in our health care system. The Coronavirus pandemic has presented an unprecedented challenge to our health care system and had a profound impact on people’s lives and livelihoods.

Weekender 3/19/2021

Thank you to the many companies that have submitted applications to present at this year’s BioNJ’s Virtual BioPartnering Conference, developed and presented in concert with J.P. Morgan and Johnson & Johnson Innovation. Thank you to our partners at JPM and J&JI for their active collaboration, engagement and counsel. It is extraordinary!

Weekender 3/5/2021

Earlier this week we released the agenda and speaker roster for our Inaugural Diversity, Equity & Inclusion…Because It Matters Conference, taking place virtually on March 24 and 25, 2021.

Weekender 2/19/2021

Now that we are one year in and vaccines are a reality, there is so much to think about and plan for! Join us next Thursday, February 25, for BioNJ’s Virtual Briefing where we’ll learn the latest on the vaccine and its variants and hear from those directly in the trenches developing plans for returning to the office and engaging with their Teams through the pandemic. Click here for details.

Weekender 2/5/2021

Thank you to everyone who joined us for yesterday’s BioNJ Board and Member Connection. We were excited to bring our Membership together for this interactive program. During yesterday’s event, BioNJ announced the election of its 2021 Officers and Board Members.

Weekender 1/22/2021

We look forward to seeing our Members on Thursday, February 4 for the first-ever BioNJ Board and Member Connection. This interactive Members-Only program is focused on providing our Members the opportunity to ENGAGE and discuss topics affecting the industry now. We’ll start by welcoming BioNJ’s next Chair of the Board and newest Board Members before hearing presentations by State representatives on New Jersey’s Vaccine Rollout Plan and the newly announced New Jersey Economic Recovery Act.

Weekender 1/8/2021

With the onset of 2021 comes hope and encouragement, as the landmark New Jersey Economic Recovery Act of 2020 was signed into law yesterday by Governor Murphy. The $14.4-billion New Jersey Economic Recovery Act of 2020 features exciting new programs as well as enhancements to existing programs that will result in economic development opportunities for New Jersey while propelling the State’s economic recovery and growth for much of the next decade.

2020

Weekender 12/14/2020

2020 has been challenging to say the least. But, with the unwavering commitment and tireless work being done by the life sciences industry here in New Jersey and beyond, there is a light at the end of the tunnel. We thank the researchers, biopharmaceutical companies, government organizations and Patients who are committed to bringing effective and safe vaccines and therapies to market.

Weekender 12/4/2020

BioNJ continues to lead the way in delivering the New Jersey life sciences message to our policymakers in Washington and Trenton. Last week, President and CEO Debbie Hart issued a statement on the misguided “Most-Favored Nation” rule related to reference pricing for Medicare Part B treatments. BioNJ also included a summary of this legislation in its most recent Public Policy Update while adding our name to a national Patient coalition letter to Congress in opposition to the rule.

Weekender 11/20/2020

It’s been an exciting week with the announcement of promising results from both Pfizer’s and Moderna’s COVID-19 vaccine candidates. As the number of cases and deaths due to the Coronavirus continue to climb at record rates, this news couldn’t come at a better time and amplifies the value, importance and impact of medical innovation. We thank the researchers, biopharmaceutical companies, government organizations and Patients who are committed to bringing effective and safe vaccines to market.

Weekender 5/22/2020

Known as the Medicine Chest of the World, New Jersey is leading the way on COVID-19 research. Join us on Friday, June 5, for a BioNJ COVID-19 Rapid Fire Research Showcase when we bring together 10 companies to share details on their groundbreaking COVID-19 research. From vaccines, cell and gene therapy, treatments and therapeutics, our presenters will highlight the important science coming from the Garden State.

Weekender 5/8/2020

Over the last few weeks, BioNJ has hosted a number of webinars under our new “Business UnUsual Webinar Series: In the Age of COVID-19,” featuring timely topics specifically focused on how they relate to the life sciences community.

Weekender 4/23/2020

We hope this letter finds you safe and well. During these most difficult times, there are numerous examples of brilliance and rays of hope being provided by New Jersey’s robust life sciences ecosystem. As always, we are happy to celebrate them and all of you who make it possible here in the BioLines Weekender!

Weekender 4/10/2020

We hope this letter finds you  safe and well.  During these sad and uncertain time s,  we continue to find hope in the tireless work being done by New Jersey’s life sciences ecosystem to bring forward antiviral therapies and vaccines to combat the virus. We thank our Members for  your commitment to Patients around the world.

Weekender 3/27/2020

We thank Governor Murphy, his Administration and the Legislature for their partnership and responsiveness to supporting the needs of our great State. We are inspired at the proactive and thoughtful approach being taken. Please visit  www.covid19.nj.gov for a comprehensive FAQ developed for businesses……… Read more.

Weekender 3/13/2020

As we navigate these uncharted waters together, we recommend that our Members refer to BioNJ’s Combating COVID-19 Toolbox for useful guidelines, policies and information on how employers are addressing employee concerns and safety needs……… Read more.

Weekender 3/13/2020

As we navigate these uncharted waters together, we recommend that our Members refer to BioNJ’s Combating COVID-19 Toolbox for useful guidelines, policies and information on how employers are addressing employee concerns and safety needs……… Read more.

Weekender 2/28/2020

BioNJ is excited to release our  2019 Annual Report Video  as debuted at our Annual Meeting on February 6. As you’ll see, 2019 was an extraordinary year for the industry, for Patients and for BioNJ!……… Read more.

Weekender 2/14/2020

The industry came out to honor New Jersey’s innovative life sciences companies and leaders, as well as the Patients who inspire them, last Thursday night at BioNJ’s 27th Annual Dinner Meeting and Innovation Celebration……… Read more.

Weekender 1/31/2020

The BioNJ Team has been busy putting finishing touches on next week’s Annual Dinner Meeting and Innovation Celebration, taking place Thursday, February 6, at the Hilton East Brunswick…….. Read more.

Weekender 1/17/2020

The BioNJ Team has been busy. Just this week, we co-hosted the Wine with BIO Friends Reception a t the J.P. Morgan Healthcare Conference and Biotech Showcase in San Francisco and the Governor’s State of the State Address…….. Read more.

Weekender 1/3/2020

2019 proved to be an exciting year for the industry with 50% of all new novel FDA drug approvals (48 new molecular entities) coming from companies with a footprint in New Jersey ……. Read more.

2019

Weekender 12/20/2019

2019 has been an exciting year for New Jersey’s life sciences ecosystem. We’ve seen the opening of new incubators supporting our emerging companies, the announcement of promising initiatives to boost New Jersey’s innovation economy by Governor Murphy…….. Read more.

Weekender 12/6/2019

New Jersey is a leading hub for the life sciences industry. The discovery and medical innovation coming from the Garden State has reached unparalleled heights…….. Read more.

Weekender 11/22/2019

We hope to see you at a future BioNJ event, including BioNJ’s Fifth Annual Inspiring Women in STEM Conference, entitled “Current and Future Progression of Women in the Workforce: Advancing Women in Life Sciences,” on December 6…….. Read more.

Weekender 11/15/2019

We hosted our 7th Annual HR Conference, entitled “HR for Life Sciences: Workforce Planning Strategy and Future Trends,” at Rutgers University in Piscataway…….. Read the full article

Weekender 10/25/2019

We are looking forward to hosting our Seventh Annual C-Suite Summit in JUST two weeks on Friday, November 8, at the Bridgewater Marriott…….. Read the full article

Weekender 10/11/2019

New Jersey is a leading hub for the life sciences industry. The discovery and medical innovation coming from the Garden State has reached unparalleled heights. We are seeing an increasing number of new therapies that have the potential to cure — not just treat……… Read the full article

Weekender 8/30/2019

We are excited to kick off an action-packed fourth quarter, featuring a number of BioNJ events! Please join us on Friday September 20, for BioNJ’s Cell and Gene Therapy Manufacturing Briefing…….. Read the full article

Weekender 8/2/2019

We opened registration for our Fourth Annual Patient Advocacy Summit, taking place October 4, at Celgene, Summit, NJ……..Read the full article

Weekender 7/19/2019

After a valiant fight, sadly, former BioNJ Chairman, Patient advocate, beloved industry member and friend Michael Becker passed away late last week ……..Read the full article

Weekender 7/3/2019

We are pleased to report that a key BioNJ policy priority has passed the Legislation and been signed by the Governor; In additional news, BioNJ recently unveiled its new “Protecting Medical Innovation: Ensuring Patient Access to Cures ” web portal ……..Read the full article

Weekender 6/21/2019

As we celebrate the first day of summer, we take a quick look back at the last two weeks filled with Member meetings, speaking opportunities, celebrations, planning and more ……..Read the full article

Weekender 6/10/2019

The great state of New Jersey was in the spotlight throughout BIO 2019 in Philadelphia which brought together over 17,000 attendees from around the world. Adding to the excitement, we released a white paper, entitled “A Framework for Demonstrating the Value of Medical Innovation” ……..Read the full article

Weekender 5/24/2019

The 2019 BIO International Convention is less than two weeks away, June 3-6 at the Pennsylvania Convention Center. Bringing together 17,000 biotechnology and pharma professionals from around the world……..Read the full article

Weekender 5/10/2019

Thank you to everyone who joined us this Wednesday for BioNJ’s 9th Annual BioPartnering Conference, developed with J.P. Morgan and Johnson & Johnson Innovation. It was a record-breaking day with 550 attendees from 17 states and 5 countries, up from 423 attendees in 2018……..Read the full article

Weekender 4/26/2019

BioNJ attended Rutgers Pharma Symposium featuring Dr. Giovanni Caforio, Chairman & CEO, Bristol-Myers Squibb and Rich Bagger, Executive Vice President, Corporate Affairs and Market Access, Celgene……..Read the full article

Weekender 3/29/2019

BioNJ participated in the inaugural meeting of the new New Jersey Commission on Science, Innovation and Technology……..Read the full article

Weekender 3/19/2019

BioNJ delivered testimony to the Assembly Commerce and Economic Growth and Senate Economic Growth Committees of the New Jersey Legislature on the State’s tax incentive programs……..Read the full article

Weekender 3/1/2019

BioNJ participated in the 82nd edition of the Walk to Washington, aka the Chamber Train, where we met with New Jersey’s Congressional Delegation and business leaders……..Read the full article

Weekender 2/15/2019

The industry came out to honor New Jersey’s innovative life sciences companies and leaders, as well as the Patients who inspire them, last Thursday night at BioNJ’s 26th Annual Dinner Meeting and Innovation Celebration. From an opening address by Governor Phil Murphy and the presentation of the 2019 Dr. Sol J. Barer Award to Dr. William Hait by Dr. Barer…….Read the full article

Weekender 2/1/2019

Since the last edition of the Weekender, we… attended a briefing meeting with the Governor’s office on the Evergreen Innovation Fund, participated in Higher Education Task Force Marketing Branding sub-committee meetings…….Read the full article

Weekender 1/18/2019

2019 has come in like a lion. From co-hosting the Wine with BIO Friends Reception and attending the  J.P. Morgan Healthcare Conference and Biotech Showcase in San Francisco to testifying before the Assembly Health and Senior Services Committee in opposition to a proposed Prescription Drug Review Commission…….Read the full article

Weekender 1/4/2019

Just prior to the New Year, Governor Murphy unveiled eight picks — including Debbie Hart, President and CEO, BioNJ; Joel Bloom, President, New Jersey Institute of Technology; and Robert Barchi, President, Rutgers University…….Read the full article

2018

Weekender 12/14/2018

2018 has been an exciting year for New Jersey’s life sciences ecosystem. We’ve seen the opening of new incubators supporting our emerging companies, the announcement of promising initiatives to boost New Jersey’s innovation economy by Governor Murphy…….Read the full article

Weekender 11/30/2018

With great enthusiasm we opened registration this week for BioNJ’s 26th Annual Dinner Meeting and Innovation Celebration taking place February 7, 2019 at the Hilton East Brunswick…….Read the full article

Weekender 11/16/2018

We held BioNJ’s Public Policy Committee Meeting, featuring guest speaker Assemblyman Andrew Zwicker, met with numerous New Jersey legislators……Read the full article

Weekender 11/2/2018

We held our Sixth Annual C-Suite Summit to discuss “Healthcare and Biopharma in Transformation: Industry’s New Edge of Opportunity.” Thank you to all who came out to participate in this important industry conversation. In addition to programming, the Team has been busy on the policy front……Read the full article

Weekender 10/19/2018

Hosted a successful Third Annual Beyond Value Frameworks: Defining the Value of Medical Innovation Workshop which brought together multi-stakeholders for an open discussion on how to become more influential regarding framework decisions to ensure Patients have access to the right medications at the right time…..Read the full article

Weekender 10/5/2018

Congratulations to William Lewis, CEO, and the entire Team at Insmed for  the ir first ever FDA approval of Arikayce, a new treatment for nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex in adults who don’t respond to conventional treatment…..Read the full article

Weekender 9/21/2018

Since the last BioLines Weekender, we participated in not one but two ribbon cuttings in addition to visiting the brand new headquarters location of OncoSec in Pennington…..Read the full article

Weekender 9/7/2018

The BioNJ Team had a great summer — cruising with our Members, planning future events and working with Governor Murphy and his Administration on initiatives to create new growth opportunities for our industry in the great state of New Jersey……Read the full article

Weekender 8/24/2018

This week we opened registration for our Sixth Annual C-Suite Summit, taking place October 25 at the Bridgewater Marriott. Entitled “Healthcare and Biopharma in Transformation: Industry’s New Edge of Opportunity,”…..Read the full article

Weekender 8/10/2018

Congratulations to BioNJ Board Advisor Dr. Andrew Pecora and the entire Team at BioNJ Member Hackensack Meridian Health on the advancements they are making to New Jersey’s innovative ecosystem. At the ribbon cutting for the Institute for Multiple Myeloma earlier this week…..Read the full article

Weekender 7/30/2018

The BioNJ Team has been enjoying its summer — cruising with our Members, planning future events and working with the administration on initiatives to create new growth opportunities for our industry in the great state of New Jersey…..Read the full article

Weekender 7/13/2018

Congratulations to Congressmen Leonard Lance and Tom MacArthur who were presented with the American Life Sciences Innovation Council’s 2018 Champion of Health Care Innovation Award…..Read the full article

Weekender 6/29/2018

Other than the budget struggles in Trenton, it’s been mostly a fun and very productive two weeks for the BioNJ Team since our last e-newsletter. We discussed the Governor Murphy Administration’s plans for advancing innovation in New Jersey with Tim Sullivan, CEO, New Jersey Economic Development Authority, during BioNJ’s Board Meeting….Read the full article

Weekender 6/15/2018

We led the New Jersey Biotechnology Task Force in its release of recommendations to boost New Jersey’s biotechnology sector, joined the New Jersey delegation at BIO in Boston, attended press conference with Governor Murphy on new STEM initiatives at Stevens Institute….Read the full article

Weekender 5/25/2018

We participated in Students 2 Science and New Jersey Innovation Institute Board Meetings, co-hosted a Congressional Staff Briefing on emergency preparedness…..Read the full article

Weekender 5/11/2018

We hosted our widely successful 8th Annual BioPartnering Conference, in partnership with J.P. Morgan, which brought together nearly 450 industry professionals (vs. 285 last year) from 18 states and 5 countries…..Read the full article

Weekender 4/20/2018

We interviewed BioNJ Entrepreneurship Fellowship candidates and extended an offer to a bright and promising candidate who will serve four 6-month rotations at Pfizer, Rafael Pharmace…..Read the full article

Weekender 4/6/2018

We chaired New Jersey Biotechnology Task Force Committee Meeting, featuring testimony from internationally recognized innovation expert Dr. Susan Windham-Bannister……Read the full article

Weekender 3/23/2018

We’ve had a couple of action-packed weeks for the BioNJ Team, with a number of exciting activities to report on. We…participated in Governor Murphy’s press conference on The Hub in New Brunswick……Read the full article

Weekender 3/9/2018

The BioNJ Team has been busy since our last Weekender, spending time with legislators, members and Patient advocates……Read the full article

Weekender 2/23/2018

It’s been a whirlwind two weeks for the BioNJ Team! We’ve…Met with Congressmen Leonard Lance and Frank Pallone to discuss important industry issues and challenges, attended the grand opening of Celgene’s CAR T facility at Summit West……Read the full article

Weekender 2/9/2018

The industry came out to honor New Jersey’s innovative life sciences companies and leaders, as well as the Patients who inspire them, last Thursday night at BioNJ’s 25th Annual Dinner Meeting and Innovation Celebration……Read the full article

Weekender 1/26/2018

Next Thursday, February 1, BioNJ will celebrate the medical innovation coming from New Jersey’s life sciences industry during its 25th Annual Dinner Meeting & Innovation Celebration. We have a lot to be proud of as New Jersey continues to be one of the top innovation hubs in the world……Read the full article

Weekender 1/12/2018

As reported by BioWorld, “2017 can be called the biggest year yet for the FDA.” With nearly 50% of all new 2017 novel drug and therapy approvals coming from companies with a footprint in New Jersey…..Read the full article

PR Newswire New Jersey Biotech News

PR Newswire has been designated by BioNJ as its preferred distributor of news releases to the life sciences news media and investment community.


CLICK HERE to get the PR NEWSWIRE NEW JERSEY Biotech News.
PR Newswire Global Biotech News

PR Newswire has been designated by BioNJ as its preferred distributor of news releases to the life sciences news media and investment community.



Click here to get the PR NEWSWIRE GLOBAL Biotech News.
Public Policy News